Japanese AIDS Vaccine To Be Clinically Tested In U.S. In '10 (Japan)
This article was originally published in PharmAsia News
A Japanese consortium including the University of Tokyo, Dnavec, and the National Institute of Infectious Diseases plans to begin clinical testing of its AIDS vaccine as early as 2010. The consortium hopes to commercialize the vaccine around 2015. The nasal spray vaccine effort will mark the first such testing of a Japanese-developed AIDS vaccine. Researchers expect the vaccine to increase the number of immune cells available to attack cells infected by HIV. The consortium found that HIV did not propagate among 60% of monkeys given the vaccine prior to being exposed to the virus. The International AIDS Vaccine Initiative will organize clinical tests involving several dozen healthy people. If the vaccine's safety and effectiveness are borne out by those tests, larger scale clinical tests will be carried out. (Click here for more - May Require Paid Subscription
You may also be interested in...
October and November 2020 were bad months for companies seeking to have their planned EU filings fast-tracked through the centralized drug review system at the European Medicines Agency.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.